Principles and criteria in the development and optimization of topical therapeutic products.
Shah
V P
VP
Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, Maryland 20857.
Behl
C R
CR
Flynn
G L
GL
Higuchi
W I
WI
Schaefer
H
H
D000279:Administration, Cutaneous; D000287:Administration, Topical; D000818:Animals; D001682:Biological Availability; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011786:Quality Control
D003879:Dermatologic Agents